Covance (CVD)
Covance EBITDA Margin TTM: 12.77%
View CVD EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CVD EBITDA Margin TTM Rankings
| Overall | 46th percentile | 2060 of 3847 |
| Sector | 59th percentile | 184 of 450 in Healthcare |
| Industry | 48th percentile | 13 of 25 in Medical Laboratories & Research |
CVD EBITDA Margin TTM Range, Past 5 Years
| Minimum | 6.83% | Mar 2011 |
| Maximum | 18.37% | Sep 2008 |
| Average | 14.77% |
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these CVD related companies
CVD News
Listen to $CVD Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eHk
about 26 days ago by earningscast
about 26 days ago by earningscast
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2012 Financial Results Conference Call
May 03, 7:00AM PR Newswire
May 03, 7:00AM PR Newswire
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2012 Financial Results Conference Call
Apr 05, 3:19PM PR Newswire
Apr 05, 3:19PM PR Newswire
$CVD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/35J7
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
Listen to $CVD Covance at Leerink Swann Global Healthcare Conference - live at 09:00 AM, ondemand after - http://stks.co/2RJD
about 103 days ago by earningscast
about 103 days ago by earningscast
Back on my short watch list again big time $CVD http://chart.ly/evl6sw7
about 107 days ago by upsidetrader
about 107 days ago by upsidetrader
$CVD New 52 Week Low - Crossed daily lows support. Next support 42.07 from 9/29/2010.
about 123 days ago by TradeIdeasQuant
about 123 days ago by TradeIdeasQuant
$CVD Covance Inc Reports Q4 EPS $0.71 vs $0.70 Est; Revenues $543.3M vs $521.52M Est
about 208 days ago by Benzinga
about 208 days ago by Benzinga
$CVD http://stks.co/rdN Arm wrestling with the 50d here. Next R at the 53.5 level. Stalking.
about 213 days ago by 1nvestor
about 213 days ago by 1nvestor
EOD: P&L -20bps, Alpha vs. S&P -272bps, Net Exposure: 121.7% long, Leverage: 47.46% Closed: Sold partial $GDX, $CVD
about 264 days ago by RSDtrading
about 264 days ago by RSDtrading
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CVD | 46.55 | +0.45 | +0.98% | 2.649B |
| CVCY | 7.50 | +0.45 | +6.38% | 71.92M |
| CVCO | 43.46 | -0.90 | -2.03% | 299.44M |
| CVC | 11.66 | +0.00 | +0.00% | 3.198B |
| CTRN | 14.11 | -0.19 | -1.33% | 210.94M |
| CTP | 6.01 | +0.00 | +0.00% | 42.73M |
| CTO | 26.99 | -0.28 | -1.03% | 157.35M |
| CTL | 38.94 | +0.24 | +0.62% | 24.13B |
| CTIC | 0.91 | -0.01 | -1.09% | 206.22M |
| CRS | 46.44 | -1.12 | -2.35% | 2.373B |
